Newtricious appoints first supervisory board
Natural ingredients specialised nutrition company Newtricious has appointed its first supervisory board.
Natural ingredients specialised nutrition company Newtricious has appointed its first supervisory board.
The supervisory board will be closely involved in strategic planning and direction of scientific research and corporate policy and will, from within its network, offer Newtricious support with regard to the internationalisation of product concepts.
The Supervisory Board comprises the following members:
- Ir. Jan Zuidam (Chairman)
- Prof. Dr. Wim van Gelder
- Ir. Jan van der Hoeven
- Drs. Susan Swarte RC
- Prof. Ir. Ena Vôute
Jan Zuidam (Chairman) started his career at DSM Research in Geleen in 1973, returning to DSM Research as director in 1992 and retired in 2010 as vice chairman of the managing board. He is currently chairman of the Limburgse Werkgevers Vereniging [Limburg Employers Association] LWV.
Professor Wim van Gelder is an internationally renowned scientist and R&D manager. As well as being author of numerous scientific and application-oriented publications, he also has a seat on a number of important national and international advisory committees.
Jan van der Hoeven won the 1984 European Environmental Mutagen Society EEMS Award for his research into the link between diet and cancer. He set up VitrOmics, a company that specialises in genomics in 2004.
Susan Swarte has extensive experience in financial and strategic management. She worked for Unilever and Numico (a Danone subsidiary), and has been CFO of the Dutch biopharmaceutical company OctoPlus since 2009.
Ena Vôute worked for Unilever during the 1990s, where she developed global brand and marketing strategies. Over the past nine years she held a number of global positions at Philips and has been head of the Industrial Design Department at the Delft University of Technology.
Related News
-
News Women in Pharma: Hiring Across the Gender Divide
In our monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
Sponsored Content Ashwagandha and Herbal Medicines: Pharma’s Next Big Opportunity
Herbal medicines and nutraceuticals have seen a surge in interest since the onset of the COVID-19 pandemic. Driven by patient interest in prioritising personalised and integrative medicines, the herbal ingredients industry is now faced with concerns pe... -
News Identifying Alzheimer’s Disease biomarker proteins with whole blood tests
A University of Manchester spin-out pharmaceutical company, PharmaKure, has reported successful study results for the quantification of Alzheimer’s Disease biomarker proteins with a whole blood test. -
News Bill & Melinda Gates Foundation to boost mRNA vaccine initiatives in Africa with USD $40m
To address vaccine inequality and accessibility issues, the Bill & Melinda Gates Foundation aims to deliver USD $40m to various biotech companies and vaccine manufacturers in support of mRNA vaccine development. -
News Updated – Changing abortion pill access according to the US FDA and Supreme Court
After the approval of the medical abortion pill, mifepristone, by the US FDA, states across the USA approach the distribution of the pill differently, some ruling against allowing access to the drug. -
News Revolutionising cancer treatment with mRNA-based therapeutics
Global market for mRNA-based oncology therapeutics expected to reach USD $2 billion by 2029, with promising results for the combination of mRNA candidates with immune checkpoint inhibitors to treat solid tumours. -
News Breaking Barriers: Innovations in Oral Solid Dose Form Bioavailability
The effectiveness of a medication often hinges on its bioavailability – the rate and extent at which the active ingredient is absorbed into the bloodstream. When it comes to oral solid dose forms, such as tablets and capsules, the challenge lies ... -
News Choosing the Right CDMO Partner: A Comprehensive Guide
Finding the right partner for the development and manufacturing of your pharmaceutical or biopharmaceutical products is paramount. This is where Contract Development and Manufacturing Organizations (CDMOs) step in, offering their expertise and infrastr...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance